English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/125488
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


5-hydroxyprostaglandin dehydrogenase expression is downregulated in hepatocellular carcinoma: role in tumor growth

AuthorsCastro-Sánchez, Luis; Agra, Noelia ; Llorente-Izquierdo, Cristina ; Motiño, Omar ; Casado, Marta ; Boscá, Lisardo ; Martín-Sanz, Paloma
Issue Date2013
CitationAASLD: The Liver Meeting (2013)
Abstract[Background and Aims]: 15-hydroxyprostaglandin dehydrogenase (15-PGDH) is a tumor suppressor in some cancers. However, no data are available regarding 15-PGDH expression in hepatocellular carcinoma (HCC). We aimed to assess the potential role of 15-PGDH in HCC. [Materials and Methods]: HCC cells lines were treated with EGF, HGF or different pharmacological inhibitors and vehicle as control. COX-2, mPGES-1 and 15-PGDH expression were analyzed by qPCR and Western-blot. Additionally, we induced 15-PGDH overexpression or silencing in a hepatoma cell line, to test in vitro cell viability, cell cycle and apoptosis markers, so as to assess tumor growth in vivo in athymic nu/nu mice. Furthermore, this study comprised a chemical model of liver cancer induced with diethylnitrosamine, a mouse model of accelerated hepatocarcinogenesis and human HCC biopsies where 15-PGDH expression was evaluated. [Results]: 15-PGDH was downregulated in human hepatoma cells with a high COX-2 and mPGES-1 expression. Moreover, EGF and HGF increased COX-2 and mPGES-1 levels and suppressed 15-PGDH expression by mainly involving ERK and p38MAPK activation. Besides, 15-PGDH expression was decreased in chemical and genetic murine models of HCC and in human HCC biopsies. Conversely, ectopic expression of 15-PGDH induced apoptosis in hepatoma cells and decreased the growth of hepatoma cells in nude mice whereas the silencing of 15-PGDH increased the tumor formation by promote increased in cell viability and Sphase cells. [Conclusion]: 15-PGDH expression is downregulated in HCC while the overexpression leads to apoptosis and may function as a relevant tumor suppressor and a potential therapeutic application in HCC.
DescriptionResumen del póster presentado al 64th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2013, celebrado en Washington (US) del 1 al 5 de noviembre de 2013.
Appears in Collections:(IIBM) Comunicaciones congresos
(IBV) Comunicaciones congresos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.